Viewing Study NCT00752518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:01 AM
Ignite Modification Date: 2026-06-25 @ 1:14 AM
Study NCT ID: NCT00752518
Status: COMPLETED
Last Update Posted: 2011-05-17
First Post: 2008-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
Sponsor: Janssen Pharmaceutical K.K.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory View
None Multiple Myeloma View
None Relapse View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bolus View
None intravenous View
None proteasome inhibitor View
None multiple myeloma View
None refractory View
None relapse View